DurAVR™ THV System: EMBARK Study
NCT: NCT05182307 · ACTIVE_NOT_RECRUITING
NCT IDNCT05182307
StatusACTIVE_NOT_RECRUITING
Start Date2021-11-15
Completion2028-04
SponsorAnteris Technologies Ltd. (INDUSTRY)
First posted
Last updated
Brief Summary
A prospective, non-randomized, single-arm, single-center, first-in-human study designed to evaluate the safety and feasibility of the DurAVR™ THV System in the treatment of subjects with symptomatic severe aortic stenosis.
Frequently Asked Questions
What is DurAVR™ THV System: EMBARK Study?
DurAVR™ THV System: EMBARK Study is a clinical trial registered under NCT05182307. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05182307?
The current status of NCT05182307 (DurAVR™ THV System: EMBARK Study) is: ACTIVE_NOT_RECRUITING.
When did DurAVR™ THV System: EMBARK Study start?
DurAVR™ THV System: EMBARK Study started on 2021-11-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.